Sonrotoclax

Sonrotoclax is a potent, orally active Bcl2 inhibitor. Sonrotoclax has effective cell killing effect against a variety of lymphoma and leukemia cell lines.


Cat. No.: EX-A8026	Purity: >98%

	Chemical structure of Sonrotoclax

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
250mg	1800	In-stock
500mg	2800	In-stock
1g	4800	In-stock
2g	get quote	In-stock
3g	get quote	In-stock
5g	get quote	In-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	BGB-11417
CAS No.	2383086-06-2
Purity	>98%
Formula	C49H59N7O7S
Mol Weight	890.1
Color	light yellow to yellow
State	solid powder
Solubility	DMSO : 100 mg/mL
Shelf Life	>3 years if stored properly
Storage	Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Nan HU, et, al. Methods of cancer treatment using bcl-2 inhibitor. WO2021110102A1.
CoA	CoA of Sonrotoclax

Smiles:	CC(C)C1=CC=CC=C1[C@@H]2CCCN2C3CC4(C3)CCN(CC4)C5=CC(=C(C=C5)C(=O)NS(=O)(=O)C6=CC(=C(C=C6)NCC7CCC(CC7)(C)O)[N+](=O)[O-])OC8=CN=C9C(=C8)C=CN9


		Search